Jill Carroll, Director, Ten Percent Owner at Applied Genetic Technologies, holds 1.48M shares in Arcellx Inc (Ticker: ACLX), holds 0.00 shares in Pandion Therapeutics (Ticker: PAND), holds 1.99M shares in Applied Genetic Technologies (Ticker: AGTC). Most recently, Jill Carroll Sold ― shares of Arcellx Inc on Mar 25, 2024 for an estimated value of 35.58M.